Prosecution Insights
Prosecution Insights
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (33%) |
| §112 only | 2 (22%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSSI, JULIA ANNE LORRAIN | 1 | 47.1% | +60.0% |
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 52.8% | +21.0% |
| YOO, SUN JAE | 1 | 71.0% | +0.3% |
| DABKOWSKI, ERINNE R | 1 | 55.8% | +69.0% |
| DAHLIN, HEATHER RAQUEL | 1 | 43.0% | +51.7% |
| LEE, HOI YAN NMN | 1 | 41.0% | +79.2% |
| WILSON, JERICA KATLYNN | 1 | 61.5% | +38.7% |
| GURLEY, JAMI MICHELLE | 1 | 54.2% | +14.3% |
| ALSOMAIRY, SARAH ABDOALATIF | 1 | 59.4% | +26.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18037105 | SALTS OF DIHYDROPYRIMIDINE DERIVATIVES, COMPLEXES AND USES THEREOF IN MEDICINE | DAHLIN, HEATHER RAQUEL | 60d overdue |
| 18563090 | A NOVEL ACYLATED INSULIN ANALOG | DABKOWSKI, ERINNE R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013619 | SALT OF 2-(SUBSTITUTED PYRIMIDINYL) THIAZOLE CARBOXAMIDE COMPOUND, AND COMPOSITION AND USE THEREOF | WILSON, JERICA KATLYNN | 155d overdue |
| 18037105 | SALTS OF DIHYDROPYRIMIDINE DERIVATIVES, COMPLEXES AND USES THEREOF IN MEDICINE | DAHLIN, HEATHER RAQUEL | 60d overdue |
| 17604728 | ANTI-TRKA ANTIBODIES AND USES THEREOF | ALSOMAIRY, SARAH ABDOALATIF | 3d overdue |
| 17627025 | CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | GURLEY, JAMI MICHELLE | 1d overdue |
| 18015138 | METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF | LEE, HOI YAN NMN | 34d |
| 18713812 | VILAZODONE COMPOSITION, PHARMACEUTICAL PREPARATION THEREOF, PREPARATION THEREFOR, AND USE THEREOF | ROSSI, JULIA ANNE LORRAIN | — |
| 18699131 | ANTIFIBROTIC COMPOSITION | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| 18563090 | A NOVEL ACYLATED INSULIN ANALOG | DABKOWSKI, ERINNE R | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1615 | 1 |
| 1617 | 1 |
| 1654 | 1 |
| 1629 | 1 |
| 1693 | 1 |
| 1647 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713812 | VILAZODONE COMPOSITION, PHARMACEUTICAL PREPARATION THEREOF, PREPARATION THEREFOR, AND USE THEREOF | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112DP | Non-Final OA | — | Pending | May 28, 2024 |
| 18699131 | ANTIFIBROTIC COMPOSITION | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18697795 | NOVEL PYRIMIDOPYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | YOO, SUN JAE | 1621 | §112 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18563090 | A NOVEL ACYLATED INSULIN ANALOG | DABKOWSKI, ERINNE R | 1654 | §103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18037105 | SALTS OF DIHYDROPYRIMIDINE DERIVATIVES, COMPLEXES AND USES THEREOF IN MEDICINE | DAHLIN, HEATHER RAQUEL | 1629 | §103§112Other | Non-Final OA | 60d overdue | Pending | May 16, 2023 |
| 18015138 | METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF | LEE, HOI YAN NMN | 1693 | §103 | Final Rejection | 34d | Pending | Jan 09, 2023 |
| 18013619 | SALT OF 2-(SUBSTITUTED PYRIMIDINYL) THIAZOLE CARBOXAMIDE COMPOUND, AND COMPOSITION AND USE THEREOF | WILSON, JERICA KATLYNN | 1621 | §112 | Non-Final OA | 155d overdue | Pending | Dec 29, 2022 |
| 17627025 | CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | GURLEY, JAMI MICHELLE | 1647 | §103 | Non-Final OA | 1d overdue | Pending | Jan 13, 2022 |
| 17604728 | ANTI-TRKA ANTIBODIES AND USES THEREOF | ALSOMAIRY, SARAH ABDOALATIF | 1646 | DP | Final Rejection | 3d overdue | Pending | Oct 18, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial